Germany: TVM Capital Life Science closes fund at US$478m

Munich and Montreal-based life sciences venture capital firm TVM Capital Life Science has closed its latest fund at US$478m. TVM Life Science Innovation II raised its funds from high-profile international investors, including Eli Lilly and Company, other strategic investors, pension funds, endowments, foundations, fund-of-funds, wealth managers and large US banks as well as multi and…

You must be a HMI Subscriber to view this content.

Subscribe Now »